Optimizing Retention in Care and Adherence to Anti-retroviral Therapy Amongst Adolescents Living With HIV in Rwanda
Human Immunodeficiency Virus
About this trial
This is an interventional supportive care trial for Human Immunodeficiency Virus
Eligibility Criteria
Inclusion Criteria:
- HIV-positive adolescents 12 to 19-years-old who are aware of their HIV-positive serostatus
- Prescribed anti-retroviral therapy for more than 1 year
- Has given informed consent with full capacity to study participation (plus parent/guardian consent as all participants will be under 21 years)
- Enrolled in care at one of the study site
Exclusion Criteria:
- HIV-negative
- HIV-positive but not prescribed ART or on ART for less than 1 year
- Not enrolled in care at the HIV clinic; younger than 12 years and older than 19 years
- No parent or named guardian who is over the age of 19 years
Sites / Locations
Arms of the Study
Arm 1
Experimental
Intervention
12-week program of combined life-skills training and financial incentives (YBank program) described in more detail below. Life-skills training: Every 4 weeks through the 12 week program, life-skills training sessions will be delivered during peer-group sessions at the clinic. Topics include economic empowerment, financial literacy, healthy relationships, and anti-retroviral therapy (ART) adherence. Financial incentives: The incentives program combines an immediate financial reward with a long-term savings opportunity. For clinic attendance, 500 RWF (~$0.50) will be deposited into participants' mobile money short-term account, where funds will be immediately accessible, and 1500 RWF (~$1.50) will be deposited into their savings account upon completing the program. If participants demonstrate a suppressed viral load at a clinic appointment, an additional 1000 RWF (~$1) will be deposited to their short-term account and 3000 RWF (~$3) into their saving account.